Brean Capital Weighs In On Medivation Following Update On Terrain Study
March 26, 2015 at 18:53 PM EDT
Medivation is best known for developing therapies to treat serious diseases. Earlier in 2014 the biopharmaceutical company received FDA approval to expand the use of Xtandi, a prescription medicine used to treat men with prostate cancer.
